Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Contact us today to schedule a consultation and start your personalized weight loss plan tailored just for you
About 43% on the highest dose reported nausea, for instance, while 33% reported diarrhea
One-on-one counseling is among the five ways a medical weight loss specialist can help you determine if these injections are right for you
Retatrutide Regulatory Status Retatrutide occupies a unique position because it is not yet FDA-approved: Not FDA-approved currently in Phase 3 clinical trials with Eli Lilly No prescription pathway in the US yet no Mounjaro/Wegovy equivalent for retatrutide Legal as research chemical sold in the US for in-vitro and animal research under research-use-only labeling Likely to receive FDA approval in coming years if clinical trial endpoints meet expectations WADA status currently not specifically listed, though peptide hormones generally fall under WADA categories Not DEA-scheduled no controlled substance status Unlike semaglutide and tirzepatide, retatrutide does not yet exist as a prescription drug
Ongoing provider check-ins to monitor progress, adjust dosing, and address any concerns
The term agonist refers to a man-made substance that interacts with your body in the same way that a naturally occurring substance does
US$ 21.03
US$ 20.80
US$ 20.35
US$ 25.69
:max_bytes(150000):strip_icc()/sofwave1-24ae8e7f91e443f895b8621590b99189.png)
